Question 1

What are the potential benefits of participating in this trial for my pancreatic cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 2

How will NMK89 help in my treatment or imaging process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of NMK89?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience any adverse effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

What this study is about

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

What this study is about